Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-9010118

  • Global Needle free Injector Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: January 2018 | Report Code: HME-9010118

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Needle free injectors are the needle free injecting syringe which utilizes high pressure narrow jets instead of needle for injecting process and are used in significant applications, delivering vaccines, insulin and pain management. The global needle free injector market is expected to have a CAGR of 15% during forecast period 2016-2023. Advantages and technological advancements associated with drug delivery technology as well as rising healthcare expenditure across the globe are some of the major factors which contributes to growth of global needle free injector market during forecast period. According to the National Center for Biotechnology Information (NCBI), United States, an advanced needle free injection system, nano particle based drug delivery systems has immense potential for the treatment of tuberculosis. Nano particle, when used as a drug carrier, is highly stable, has high carrier capacity and can be used for sustained drug release.

The key factor driving the growth of global needle free injector market is the surging demand for self-injection devices. There is a rising penetration of self-injection techniques and technologies in Asia Pacific countries, such as China, India, Japan, etc. and adds up to the demand for injectable devices in the APAC region. Moreover, self-injection devices are being extensively used for the treatment for various diseases. For instance, intracavernosal self-injection treatment is used for erectile dysfunction (ED) in order to facilitate easier drug administration, and minimize the artificiality of intracavernosal pharmacotheraphy. Due to the development of self-injection devices, patient compliance has been improved as it is safe, cost-effective, comfortable, easy and convenient to use. The Food and Drug Administration had issued additional usability guidelines and more in-depth requirements for Human Factors Engineering (HFE) in order to ensure that self-injection devices are more intuitive and easy to use, safer, and have high accuracy in order to ensure that patients can avail the effective treatment. Moreover, self-injection devices are required to meet age related requirements such as pediatrics Furthermore, certain patients might suffer from physical limitations related to vision, dexterity, etc. which may have large impact on the overall device design and feature set of self-injection device. In 2015, Sandoz had launched SurePal which is a reusable self-injection system primarily developed to support the daily administration of Omnitrope (form of human growth hormone). Therefore, the increasing demand for self-injection devices is expected to positively influence the market growth.

Source: OBRC Analysis.

The report on global needle free injector market includes technologies, site of delivery, types of medication, usability, product, end users and applications.  

Technologies used in needle free injector include:

·         Jet-based needle-free injectors

·         Laser-powered needle-free injectors

·         Spring-based needle-free injectors

·         Vibration-based needle-free injectors

Site of delivery segment is segmented into:

·         Intra dermal injectors

·         Intramuscular injectors

·         Subcutaneous injectors

Type of medication includes:

·         Liquid-based needle free injectors

·         Powder-based needle free injectors

·         Projectile/depot-based needle free injectors

Usability of needle free injector includes:

·         Reusable needle-free injectors

·         Disposable Needle-Free Injectors

Products of needle free injector includes:

·         Fillable Needle-Free Injectors

·         Prefilled Needle-Free Injectors

End users of needle free injector include:

·         Hospital and clinics

·         Home care settings

·         Research laboratories

·         Other

The applications of needle free injector include:

·         Vaccine needle free delivery

·         Insulin needle free delivery

·         Pain management needle free delivery

·         Oncology needle free delivery

·         Others

The global needle free injector market report has been geographically segmented in:

·         North America (U.S. & Canada)

·         Asia Pacific (China, India, Japan, RoAPAC)

·         Europe (UK, France, Germany, RoE)

·         Rest of World

Geographically, North America accounts for the highest revenue share of the needle free injector market. The key factor contributing to the North American needle free injector market is increasing cases of chronic diseases such as cancer, Alzheimer’s, stroke, etc. According to Center for Disease Control and Prevention, stroke is the third leading cause of death in United States. Every year around 140,000 Americans die from stroke. Death due to stroke in the US accounts for about 1 in every 4 minutes. Every year more than 795,000 people in United States suffer from stroke. Furthermore, according to National Cancer Institute, in 2016, around 1,685,210 new cases of cancer diagnosed in United States and about 595,690 people died from cancer. In addition, rise in prevalence of diabetes raise the demand for needle free insulin delivery devices in North America. In 2015, around 30.3 million people or 9.4% of the total population of United States suffered with diabetes as per the Centers for Disease Control and Prevention. However, Europe is anticipated to emerge as the fastest growing market during forecast period owing to rising demand for biologics in European region.

Global needle free injector market report covers segmentation analysis of technologies, site of delivery, types of medication, usability, products, end users and applications. Report further covers segments of technology which include jet-based, laser-powered, spring-based and vibration-based needle free injector. The jet based needle free injector is the dominating segment owing to its advantages over other technologies. Report further covers segments of site of delivery which include intra dermal injectors, intramuscular injectors and subcutaneous injectors. Types of medication include Liquid-based, Powder-based and Projectile/depot-based needle free injectors. Liquid based needle free injector is the leading medication segment as it is flexible to use. Furthermore, on the basis of products, the market is segmented into Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors. The end users of needle free injector are hospital and clinics, home care settings, research laboratories and others.

The major market players of the global needle free injector market are:

·         ENDO INTERNATIONAL PLC

·         CROSSJECT

·         ASTRAZENECA

·         ASIA PHARMA PHARMACEUTICAL LTD

·         OTHERS

These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, product and service launch is the key strategy adopted by the companies in the global needle free injector market.

For Example; in 2016, AstraZeneca launched Bydureon, a pre-filled insulin pen which simplify the injections process by removing the need to transfer the medicine between the vial and syringe.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in global needle free injector market.  

Key reason to buy the report:

·         The report includes market estimation, forecast and analysis for the year 2016-2023

·         Report includes detailed analysis of different segments such as technologies, site of delivery, types of medication, usability, product, end users and applications of needle free injector.

·         Identify and understand the strengths, opportunities, challenges and threats of the global needle free injector market.

·         Covers detailed analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of the global needle free injector market.

·         Detailed analysis of various regulatory policies which are affecting the global needle free injector market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global needle free injector market offers detailed analysis of strategic models, such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the needle free injector market with giving extensive SCOT analysis of key companies. 

Key findings of the global needle free injector market

·         The key factor driving the growth of global needle free injector market is the surging demand for self-injection devices.

·         North America is the largest market for global needle free injectors in terms of market revenue share.

·         Jet based needle free injector is the leading technology segment.

·         Product and service launch is the key strategy adopted by the companies in the global needle free injector market. 

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
 
2.1. GLOBAL NEEDLE FREE INJECTOR MARKET : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS 
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
3.1.2. RISING INCIDENCE OF COMMUNICABLE DISEASES DUE TO NEEDLE STICK INJURIES
3.1.3. GROWING DEMAND FOR SELF-INJECTION DEVICES
3.1.4. ADVANTAGES OF DRUG DELIVERY TECHNOLOGY
3.2. MARKET RESTRAINTS
3.2.1. ALTERNATIVE MODES OF DRUG DELIVERY
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING DEMAND FOR BIOSIMILARS AND VACCINATION
3.3.2. EMERGING MARKETS OF NEEDLE FREE INJECTION
3.4.   MARKET CHALLENGES 
3.4.1. NEED TO ENSURE SYSTEM STERILITY
3.4.2. HIGHER COST OF DEVELOPMENT
 
4. MARKET SEGMENTATION 
4.1. GLOBAL NEEDLE FREE INJECTOR MARKET BY END USER
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL HOSPITAL & CLINICS MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL HOME CARE SETTINGS MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL RESEARCH LABORATORIES MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL OTHER END USER MARKET 
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.4.4. KEY CONCLUSIONS
4.2. GLOBAL NEEDLE FREE INJECTOR MARKET BY SITE OF DELIVERY 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL INTRADERMAL INJECTORS MARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL INTRAMUSCULAR INJECTORS MARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL SUBCUTANEOUS INJECTORS MARKET 
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.4. KEY CONCLUSIONS
4.3. GLOBAL NEEDLE FREE INJECTOR MARKET BY APPLICATION 
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL VACCINE NEEDLE FREE DELIVERY MARKET 
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL INSULIN NEEDLE FREE DELIVERY MARKET 
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL PAIN MANAGEMENT NEEDLE FREE DELIVERY MARKET 
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL ONCOLOGY NEEDLE FREE DELIVERY MARKET 
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL OTHERS APPLICATIONS MARKET 
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.5.4. KEY CONCLUSIONS
4.4. GLOBAL NEEDLE FREE INJECTOR MARKET BY TYPE OF MEDICATION
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL LIQUID-BASED NEEDLE FREE INJECTORS MARKET 
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL POWDER-BASED NEEDLE FREE INJECTORS MARKET 
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS MARKET 
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
4.5. GLOBAL NEEDLE FREE INJECTOR MARKET BY USABILITY 
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION 
4.5.5.1. GLOBAL DISPOSABLE NEEDLE-FREE INJECTORS MARKET 
4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.1.4. KEY CONCLUSIONS
4.5.5.2. GLOBAL REUSABLE NEEDLE-FREE INJECTORS MARKET 
4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.2.4. KEY CONCLUSIONS
4.6. GLOBAL NEEDLE FREE INJECTOR MARKET BY PRODUCT 
4.6.1. MARKET DEFINITION AND SCOPE
4.6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.6.4. OPPORTUNITY MATRIX
4.6.5. MARKET SEGMENTATION 
4.6.5.1. GLOBAL FILLABLE NEEDLE-FREE INJECTORS MARKET 
4.6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.6.5.1.4. KEY CONCLUSIONS
4.6.5.2. GLOBAL PREFILLED NEEDLE-FREE INJECTORS MARKET 
4.6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.6.5.2.4. KEY CONCLUSIONS
4.7. GLOBAL NEEDLE FREE INJECTOR MARKET BY TECHNOLOGY
4.7.1. MARKET DEFINITION AND SCOPE
4.7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.7.4. OPPORTUNITY MATRIX
4.7.5. MARKET SEGMENTATION 
4.7.5.1. GLOBAL JET-BASED NEEDLE-FREE INJECTORS MARKET 
4.7.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.7.5.1.4. KEY CONCLUSIONS
4.7.5.2. GLOBAL LASER-POWERED NEEDLE-FREE INJECTORS MARKET 
4.7.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.7.5.2.4. KEY CONCLUSIONS
4.7.5.3. GLOBAL SPRING-BASED NEEDLE-FREE INJECTORS MARKET 
4.7.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.7.5.3.4. KEY CONCLUSIONS
4.7.5.4. GLOBAL VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET 
4.7.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.7.5.4.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL NEEDLE FREE INJECTOR MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY  PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY  PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY  PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ASIA PHARMA PHARMACEUTICAL LTD (MALAYSIA)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. ASTRAZENECA(ENGLAND)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. BIOJECT MEDICAL TECHNOLOGIES (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. CROSSJECT (FRANCE)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. ENDO INTERNATIONAL PLC (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. ENVISION PHARMA GROUP (ENGLAND)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. INJEX PHARMA AG (GERMANY)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. INOVIO PHARMACEUTICALS INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. MEDICAL INTERNATIONAL TECHNOLOGY INC. (CANADA)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. MERCK (U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. MYLAN (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. NATIONAL MEDICAL PRODUCTS INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. PHARMAJET (U.S.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. VALERITAS INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ZOGENIX (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS 
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL NEEDLE FREE INJECTOR MARKET BY END USER 2014 -2023 ($ MILLION)
2. GLOBAL HOSPITALS AND CLINICS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
3. GLOBAL HOME CARE SETTINGS MARKET BY GEOGRAPHY 2014-2022, ($ MILLIONS)
4. GLOBAL RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
5. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
6. GLOBAL OTHER END USERS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
7. GLOBAL NEEDLE FREE INJECTOR MARKET BY USABILITY 2014 -2023 ($ MILLION)
8. GLOBAL DISPOSABLE NEEDLE-FREE INJECTORS MARKET GEOGRAPHY 2014 -2023 ($ MILLION)
9. GLOBAL REUSABLE NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
10. GLOBAL NEEDLE FREE INJECTOR MARKET BY APPLICATION 2014 -2023 ($ MILLION)
11. GLOBAL VACCINE NEEDLE FREE DELIVERY MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
12. GLOBAL INSULIN NEEDLE FREE DELIVERY MARKET BY GEOGRAPHY2014 -2023 ($ MILLION)
13. GLOBAL PAIN MANAGEMENT NEEDLE FREE DELIVERY  MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
14. GLOBAL ONCOLOGY NEEDLE FREE DELIVERY MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
15. GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
16. GLOBAL NEEDLE FREE INJECTOR MARKET BY  SITE OF DELIVERY 2014 -2023 ($ MILLION)
17. GLOBAL SUBCUTANEOUS INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
18. GLOBAL INTRAMUSCULAR INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
19. GLOBAL INTRADERMAL INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
20. GLOBAL NEEDLE FREE INJECTOR MARKET BY  TYPE 2014 -2023 ($ MILLION)
21. GLOBAL LIQUID-BASED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
22. GLOBAL PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
23. GLOBAL POWDER-BASED NEEDLE FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
24. GLOBAL NEEDLE FREE INJECTOR MARKET BY  TECHNOLOGY 2014 -2023 ($ MILLION)
25. GLOBAL JET-BASED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
26. GLOBAL SPRING-BASED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
27. GLOBAL LASER-POWERED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
28. GLOBAL VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
29. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET BY PRODUCT 2014 -2023 ($ MILLION)
30. GLOBAL FILLABLE NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
31. GLOBAL PREFILLED NEEDLE-FREE INJECTORS MARKET BY GEOGRAPHY 2014 -2023 ($ MILLION)
32. NORTH AMERICA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
33. EUROPE NEEDLE FREE INJECTOR  MARKET 2014-2023 ($ MILLION)
34. ASIA PACIFIC NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
35. REST OF THE WORLD NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL HOSPITALS AND CLINICS MARKET 2014 -2023 ($ MILLION)
2. GLOBAL HOME CARE SETTINGS MARKET 2014 -2023 ($ MILLION)
3. GLOBAL RESEARCH LABORATORIES MARKET 2014-2022 ($ MILLIONS)
4. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2014 -2023 ($ MILLION)
5. GLOBAL OTHER END USERS  MARKET 2014 -2023 ($ MILLION)
6. GLOBAL DISPOSABLE NEEDLE-FREE INJECTORS MARKET 2014 -2023 ($ MILLION)
7. GLOBAL REUSABLE NEEDLE-FREE INJECTORS 2014 -2023 ($ MILLION)
8. GLOBAL VACCINE NEEDLE FREE DELIVERY MARKET 2014 -2023 ($ MILLION)
9. GLOBAL INSULIN NEEDLE FREE DELIVERY MARKET 2014 -2023 ($ MILLION)
10. GLOBAL PAIN MANAGEMENT NEEDLE FREE DELIVERY  MARKET 2014 -2023 ($ MILLION)
11. GLOBAL ONCOLOGY NEEDLE FREE DELIVERY MARKET 2014 -2023 ($ MILLION)
12. GLOBAL OTHER APPLICATIONS  MARKET 2014 -2023 ($ MILLION)
13. GLOBAL SUBCUTANEOUS INJECTORS  MARKET 2014 -2023 ($ MILLION)
14. GLOBAL INTRAMUSCULAR INJECTORS MARKET 2014 -2023 ($ MILLION)
15. GLOBAL LIQUID-BASED NEEDLE-FREE INJECTORS MARKET  2014 -2023 ($ MILLION)
16. GLOBAL PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS MARKET 2014 -2023 ($ MILLION)
17. GLOBAL POWDER-BASED NEEDLE FREE INJECTORS MARKET 2014 -2023 ($ MILLION)
18. GLOBAL JET-BASED NEEDLE-FREE INJECTORS MARKET 2014 -2023 ($ MILLION)
19. GLOBAL SPRING-BASED NEEDLE-FREE INJECTORS  MARKET 2014 -2023 ($ MILLION)
20. GLOBAL LASER-POWERED NEEDLE-FREE INJECTORS  MARKET 2014 -2023 ($ MILLION)
21. GLOBAL VIBRATION-BASED NEEDLE-FREE INJECTORS 2014 -2023 ($ MILLION)
22. GLOBAL FILLABLE NEEDLE-FREE INJECTORS 2014 -2023 ($ MILLION)
23. GLOBAL PREFILLED NEEDLE-FREE INJECTORS 2014 -2023 ($ MILLION)
24. UNITED STATES (U.S.) NEEDLE FREE INJECTOR  MARKET 2014-2023 ($ MILLION)
25. CANADA NEEDLE FREE INJECTOR  MARKET 2014-2023 ($ MILLION)
26. UNITED KINGDOM (UK) NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
27. FRANCE NEEDLE FREE INJECTOR  MARKET 2014-2023 ($ MILLION)
28. GERMANY NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
29. SPAIN NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
30. ROE NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
31. INDIA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
32. CHINA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
33. JAPAN NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
34. AUSTRALIA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
35. ROAPAC NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
36. LATIN AMERICA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)
37. MENA NEEDLE FREE INJECTOR MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion